Ubiquitin-like protein modifications in prostate and breast cancer

Frontiers in Bioscience

Volumn 12, Issue 2, 2007, Pages 700-711

  Wu, Fangting ^a   Mo, Yin Yuan ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Posttranslational modification; Prostate cancer and breast cancer; Sumoylation; Ubc9; Ubiquitin like protein

Indexed keywords

EID: 34249796386     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2094     Document Type: Article

References (119)

1. Lipkowitz, S.: The role of the ubiquitination-proteasome pathway in breast cancer: ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer. Breast Cancer Res, 5, 8-15 (2003)
2. Gill, G.: SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev, 18, 2046-59 (2004)
3. Melchior, F.: SUMO-nonclassical ubiquitin. Annu Rev Cell Dev Biol, 16, 591-626 (2000)
4. Johnson, E. S.: Protein modification by SUMO. Annu Rev Biochem, 73, 355-82 (2004)
5. Muller, S., C. Hoege, G. Pyrowolakis & S. Jentsch: SUMO, ubiquitin's mysterious cousin. Nat Rev Mol Cell Biol, 2, 202-10 (2001)
6. Seeler, J. S. & A. Dejean: Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol, 4, 690-9 (2003)
7. Dohmen, R. J.: SUMO protein modification. Biochim Biophys Acta, 1695, 113-31 (2004)
8. Bayer, P., A. Arndt, S. Metzger, R. Mahajan, F. Melchior, R. Jaenicke & J. Becker: Structure determination of the small ubiquitin-related modifier SUMO-1. J Mol Biol, 280, 275-86 (1998)
9. Jin, C., T. Shiyanova, Z. Shen & X. Liao: Heteronuclear nuclear magnetic resonance assignments, structure and dynamics of SUMO-1, a human ubiquitin-like protein. Int J Biol Macromol, 28, 227-34 (2001)
10. Kim, K. I., S. H. Baek, Y. J. Jeon, S. Nishimori, T. Suzuki, S. Uchida, N. Shimbara, H. Saitoh, K. Tanaka & C. H. Chung: A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J Biol Chem, 275, 14102-6 (2000)
11. Li, Y., H. Wang, S. Wang, D. Quon, Y. W. Liu & B. Cordell: Positive and negative regulation of APP amyloidogenesis by sumoylation. Proc Natl Acad Sci U S A, 100, 259-64 (2003)
12. Li, M., D. Guo, C. M. Isales, D. L. Eizirik, M. Atkinson, J. X. She & C. Y. Wang: SUMO wrestling with type 1 diabetes. J Mol Med (2005)
13. Tatham, M. H., E. Jaffray, O. A. Vaughan, J. M. Desterro, C. H. Botting, J. H. Naismith & R. T. Hay: Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem, 276, 35368-74 (2001)
14. Saitoh, H. & J. Hinchey: Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem, 275, 6252-8 (2000)
15. Bylebyl, G. R., I. Belichenko & E. S. Johnson: The SUMO isopeptidase Ulp2 prevents accumulation of SUMO chains in yeast. J Biol Chem, 278, 44113-20 (2003)
16. Johnson, E. S., I. Schwienhorst, R. J. Dohmen & G. Blobel: The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. Embo J, 16, 5509-19 (1997)
17. Azuma, Y., S. H. Tan, M. M. Cavenagh, A. M. Ainsztein, H. Saitoh & M. Dasso: Expression and regulation of the mammalian SUMO-1 El enzyme. Faseb J, 15, 1825-7 (2001)
18. Boggio, R., R. Colombo, R. T. Hay, G. F. Draetta & S. Chiocca: A mechanism for inhibiting the SUMO pathway. Mol Cell, 16, 549-61 (2004)
19. Bencsath, K. P., M. S. Podgorski, V. R. Pagala, C. A. Slaughter & B. A. Schulman: Identification of a multifunctional binding site on Ubc9p required for Smt3p conjugation. J Biol Chem, 277, 47938-45 (2002)
20. Rodriguez, M. S., C. Dargemont & R. T. Hay: SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem, 276, 12654-9 (2001)
21. Bernier-Villamor, V., D. A. Sampson, M. J. Matunis & C. D. Lima: Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell, 108, 345-56 (2002)
22. Lin, D., M. H. Tatham, B. Yu, S. Kim, R. T. Hay & Y. Chen: Identification of a substrate recognition site on Ubc9. J Biol Chem, 277, 21740-8 (2002)
23. Giorgino, F., O. de Robertis, L. Laviola, C. Montrone, S. Perrini, K. C. McCowen & R. J. Smith: The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells. Proc Natl Acad Sci U S A, 97, 1125-30 (2000)
24. Mo, Y. Y., Y. Yu, Z. Shen & W. T. Beck: Nucleolar delocalization of human topoisomerase I in response to topotecan correlates with sumoylation of the protein. J Biol Chem, 211, 2958-64 (2002)
25. Johnson, E. S. & A. A. Gupta: An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell, 106, 735-44 (2001)
26. Kahyo, T., T. Nishida & H. Yasuda: Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell, 8, 713-8 (2001)
27. Pichler, A., A. Gast, J. S. Seeler, A. Dejean & F. Melchior: The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell, 108, 109-20 (2002)
28. Kagey, M. H., T. A. Melhuish & D. Wotton: The polycomb protein Pc2 is a SUMO E3. Cell, 113, 127-37 (2003)
29. Li, S. J. & M. Hochstrasser: A new protease required for cell-cycle progression in yeast. Nature, 398, 246-51 (1999)
30. Li, S. J. & M. Hochstrasser: The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein. Mol Cell Biol, 20, 2367-77 (2000)
31. Gong, L., S. Millas, G. G. Maul & E. T. Yeh: Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J Biol Chem, 215, 3355-9 (2000)
32. Nishida, T., F. Kaneko, M. Kitagawa & H. Yasuda: Characterization of a novel mammalian SUMO-1/Smt3-specific isopeptidase, a homologue of rat axam, which is an axin-binding protein promoting beta-catenin degradation. J Biol Chem, 276, 39060-6 (2001)
33. Nishida, T., H. Tanaka & H. Yasuda: A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur J Biochem, 267, 6423-7 (2000)
34. Bailey, D. & P. O'Hare: Herpes simplex virus 1 ICPO co-localizes with a SUMO-specific protease. J Gen Virol, 83, 2951-64 (2002)
35. Hang, J. & M. Dasso: Association of the human SUMO-1 protease SENP2 with the nuclear pore. J Biol Chem, 211, 19961-6 (2002)
36. Wykoff, D. D. & E. K. O'Shea: Identification of sumoylated proteins by systematic immunoprecipitation of the budding yeast proteome. Mol Cell Proteomics, 4, 73-83 (2005)
37. Zhou, F., Y. Xue, H. Lu, G. Chen & X. Yao: A genome-wide analysis of sumoylation-related biological processes and functions in human nucleus. FEBS Lett, 579, 3369-75 (2005)
38. Matunis, M. J., E. Coutavas & G. Blobel: A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol, 135, 1457-70 (1996)
39. Mahajan, R., C. Delphin, T. Guan, L. Gerace & F. Melchior: A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell, 88, 97-107 (1997)
40. Lin, X., B. Sun, M. Liang, Y. Y. Liang, A. Gast, J. Hildebrand, F. C. Brunicardi, F. Melchior & X. H. Feng: Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol Cell, 11, 1389-96 (2003)
41. Endter, C., J. Kzhyshkowska, R. Stauber & T. Dobner: SUMO-1 modification required for transformation by adenovirus type 5 early region IB 55-kDa oncoprotein. Proc Natl Acad Sei USA, 98, 11312-7 (2001)
42. Comerford, K. M., M. O. Leonard, J. Karhausen, R. Carey, S. P. Colgan & C. T. Taylor: Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc Natl Acad Sci USA, 100, 986-91 (2003)
43. Huang, T. T., S. M. Wuerzberger-Davis, Z. H. Wu & S. Miyamoto: Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell, 115, 565-76 (2003)
44. Duprez, E., A. J. Saurin, J. M. Desterro, V. Lallemand-Breitenbach, K. Howe, M. N. Boddy, E. Solomon, H. de The, R. T. Hay & P. S. Freemont: SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci, 112 (Pt 3), 381-93 (1999)
45. Zhong, S., S. Muller, S. Ronchetti, P. S. Freemont, A. Dejean & P. P. Pandolfi: Role of SUMO-1-modified PML in nuclear body formation. Blood, 95, 2748-52 (2000)
46. Lamond, A. I. & D. L. Specter: Nuclear speckles: a model for nuclear organelles. Nat Rev Mol Cell Biol, 4, 605-12 (2003)
47. Ishov, A. M., A. G. Sotnikov, D. Negorev, O. V. Vladimirova, N. Neff, T. Kamitani, E. T. Yeh, J. F. Strauss, 3rd & G. G. Maul: PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol, 147,221-34 (1999)
48. Best, J. L., S. Ganiatsas, S. Agarwal, A. Changou, P. Salomoni, O. Shirihai, P. B. Meluh, P. P. Pandolfi & L. I. Zon: SUMO-1 protease-1 regulates gene transcription through PML. Mol Cell, 10, 843-55 (2002)
49. Rallabhandi, P., K. Hashimoto, Y. Y. Mo, W. T. Beck, P. K. Moitra & P. D'Arpa: Sumoylation of topoisomerase I is involved in its partitioning between nucleoli and nucleoplasm and its clearing from nucleoli in response to camptothecin. J Biol Chem, 277, 40020-6 (2002)
50. Dobreva, G., J. Dambacher & R. Grosschedl: SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev, 17, 3048-61 (2003)
51. Muller, S., A. Ledl & D. Schmidt: SUMO: a regulator of gene expression and genome integrity. Oncogene, 23, 1998-2008 (2004)
52. Hong, Y., R. Rogers, M. J. Matunis, C. N. Mayhew, M. L. Goodson, O. K. Park-Sarge & K. D. Sarge: Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification. J Biol Chem, 276, 40263-7 (2001)
53. Gostissa, M., A. Hengstermann, V. Fogal, P. Sandy, S. E. Schwarz, M. Scheffner & G. Del Sal: Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. Embo J, 18, 6462-71 (1999)
54. Gomez-del Arco, P., J. Koipally & K. Georgopoulos: Ikaros SUMOylation: switching out of repression. Mol Cell Biol, 25, 2688-97 (2005)
55. Eloranta, J. J. & H. C. Hurst: Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo. J Biol Chem, 277, 30798-804 (2002)
56. Girdwood, D., D. Bumpass, O. A. Vaughan, A. Thain, L. A. Anderson, A. W. Snowden, E. Garcia-Wilson, N. D. Perkins & R. T. Hay: P300 transcriptional repression is mediated by SUMO modification. Mol Cell, 11, 1043-54 (2003)
57. Chalkiadaki, A. & I. Talianidis: SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin. Mol Cell Biol, 25, 5095-105 (2005)
58. Yang, S. H. & A. D. Sharrocks: SUMO promotes HDAC-mediated transcriptional repression. Mol Cell, 13, 611-7 (2004)
59. Shiio, Y. & R. N. Eisenman: Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci U S A, 100, 13225-30 (2003)
60. Rodriguez, M. S., J. M. Desterro, S. Lain, C A. Midgley, D. P. Lane & R. T. Hay: SUMO-1 modification activates the transcriptional response of p53. Embo J, 18, 6455-61 (1999)
61. Desterro, J. M., M. S. Rodriguez & R. T. Hay: SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell, 2, 233-9 (1998)
62. Lin, X., M. Liang, Y. Y. Liang, F. C. Brunicardi & X. H. Feng: SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J Biol Chem, 278, 31043-8 (2003)
63. Steffan, J. S., N. Agrawal, J. Pallos, E Rockabrand, L. C. Trotman, N. Slepko, K. Illes, T. Lukacsovich, Y. Z. Zhu, E. Cattaneo, P. P. Pandolfi, L. M. Thompson & J. L. Marsh: SUMO modification of Huntingtin and Huntington's disease pathology. Science, 304, 100-4 (2004)
64. Shao, R., F. P. Zhang, F. Tian, P. Anders Friberg, X. Wang, H. Sjoland & H. Billig: Increase of SUMO-1 expression in response to hypoxia: direct interaction with HIF-1 alpha in adult mouse brain and heart in vivo. FEBS Lett, 569, 293-300 (2004)
65. Rosendorff, A., D. Illanes, G. David, J. Lin, E. Kieff & E. Johannsen: EBNA3C coactivation with EBNA2 requires a SUMO homology domain. J Virol, 78, 367-77 (2004)
66. Song, J., Z. Zhang, W. Hu & Y. Chen: SUMO recognition of a SUMO-binding motif: A reversal of the bound orientation. J Biol Chem (2005)
67. Hoege, C., B. Pfander, G. L. Moldovan, G. Pyrowolakis & S. Jentsch: RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature, 419, 135-41 (2002)
68. Stelter, P. & H. D. Ulrich: Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature, 425, 188-91 (2003)
69. Papouli, E., S. Chen, A. A. Davies, D. Huttner, L. Krejci, P. Sung & H. D. Ulrich: Crosstalk between SUMO and ubiquitin on PCNA is mediated by recruitment of the helicase Srs2p. Mol Cell, 19, 123-33 (2005)
70. Pfander, B., G. L. Moldovan, M. Sacher, C. Hoege & S. Jentsch: SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase. Nature, 436, 428-33 (2005)
71. Haracska, L., C. A. Torres-Ramos, R. E. Johnson, S. Prakash & L. Prakash: Opposing effects of ubiquitin conjugation and SUMO modification of PCNA on replicational bypass of DNA lesions in Saccharomyces cerevisiae. Mol Cell Biol, 24, 4267-74 (2004)
72. Kannouche, P. L., J. Wing & A. R. Lehmann: Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol Cell, 14, 491-500 (2004)
73. Wang, Q. E., Q. Zhu, G. Wani, M. A. El-Mahdy, J. Li & A. A. Wani: DNA repair factor XPC is modified by SUMO-1 and ubiquitin following UV irradiation. Nucleic Acids Res, 33, 4023-34 (2005)
74. Watanabe, K., S. Tateishi, M. Kawasuji, T. Tsurimoto, H. Inoue & M. Yamaizumi: Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination. Embo J, 23, 3886-96 (2004)
75. Kwek, S. S., J. Deny, A. L. Tyner, Z. Shen & A. V. Gudkov: Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene, 20, 2587-99 (2001)
76. Schmidt, D. & S. Muller: Members of the PIAS family act as SUMO ligases for o-Jun and p53 and repress p53 activity. Proc Natl Acad Sci U S A, 99, 2872-7 (2002)
77. Shinbo, Y., T. Niki, T. Taira, H. Ooe, K. Takahashi-Niki, C. Maita, C. Seino, S. M. Iguchi-Ariga & H. Ariga: Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities. Cell Death Differ (2005)
78. Chakrabarti, S. R., R. Sood, S. Ganguly, S. Bohlander, Z. Shen & G. Nucifora: Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9. Proc Natl Acad Sci U S A, 96, 7467-72 (1999)
79. Ledl, A., D. Schmidt & S. Muller: Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Oncogene, 24, 3810-8 (2005)
80. Mo, Y. Y., Y. Yu, E. Theodosiou, P. L. Rachel Ee & W. T. Beck: A role for Ubc9 in tumorigenesis. Oncogene, 24, 2677-83 (2005)
81. Wang, L. & S. Banerjee: Differential PIAS3 expression in human malignancy. Oncol Rep, 11, 1319-24 (2004)
82. Lee, J. S., I. S. Chu, J. Heo, D. F. Calvisi, Z. Sun, T. Roskams, A. Durnez, A. J. Demetris & S. S. Thorgeirsson: Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology, 40, 667-76 (2004)
83. Wu, Q., X. F. Lin, X. F. Ye, B. Zhang, Z. Xie & W. J. Su: Ubiquitinated or sumoylated retinoic acid receptor alpha determines its characteristic and interacting model with retinoid X receptor alpha in gastric and breast cancer cells. J Mol Endocrinol, 32, 595-613 (2004)
84. Mo, Y. Y., Y. Yu, P. L. Ee & W. T. Beck: Overexpression of a dominant-negative mutant Ubc9 is associated with increased sensitivity to anticancer drugs. Cancer Res, 64, 2793-8 (2004)
85. Chang, H. Y., H. Nishitoh, X. Yang, H. Ichijo & D. Baltimore: Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science, 281, 1860-3 (1998)
86. Xu, L., C. K. Glass & M. G. Rosenfeld: Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev, 9, 140-7 (1999)
87. Chauchereau, A., L. Amazit, M. Quesne, A. GuiochonMantel & E. Milgrom: Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. J Biol Chem, 278, 12335-43 (2003)
88. Le Drean, Y., N. Mincheneau, P. Le Goff & D. Michel: Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology, 143, 3482-9 (2002)
89. Nishida, T. & H. Yasuda: PIAS1 and PIASxalpha function as SUMOE3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. J Biol Chem, 211, 41311-7 (2002)
90. Ohshima, T., H. Koga & K. Shimotohno: Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification. J Biol Chem, 279, 29551-7 (2004)
91. Pascual, G., A. L. Fong, S. Ogawa, A. Gamliel, A. C. Li, V. Perissi, D. W. Rose, T. M. Willson, M. G. Rosenfeld & C. K. Glass: A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature, 437, 759-63 (2005)
92. Gelmann, E. P.: Molecular biology of the androgen receptor. J Clin Oncol, 20, 3001-15 (2002)
93. McKenna, N. J. & B. W. O'Malley: Combinatorial control of gene expression by nuclear receptors and coregulators. Cell, 108, 465-74 (2002)
94. Heinlein, C. A. & C. Chang: Androgen receptor (AR) coregulators: an overview. Endocr Rev, 23, 175-200 (2002)
95. Shang, Y., M. Myers & M. Brown: Formation of the androgen receptor transcription complex. Mol Cell, 9, 601-10 (2002)
96. Poukka, H., U. Karvonen, O. A. Janne & J. J. Palvimo: Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci U S A, 97, 14145-50 (2000)
97. Iniguez-Lluhi, J. A. & D. Pearce: A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol Cell Biol, 20, 6040-50 (2000)
98. Callewaert, L., G. Verrijdt, A. Haelens & F. Ciaessens: Differential effect of small ubiquitin-like modifier (SUMO)-ylation of the androgen receptor in the control of cooperativity on selective versus canonical response elements. Mol Endocrinol, 18, 1438-49 (2004)
99. Glass, C. K. & M. G. Rosenfeld: The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev, 14, 121-41 (2000)
100. Fu, M., C. Wang, X. Zhang & R. G. Pestell: Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem Pharmacol, 68, 1199-208 (2004)
101. David, G., M. A. Neptune & R. A. DePinho: SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J Biol Chem, 277, 23658-63 (2002)
102. Kotaja, N., U. Karvonen, O. A. Janne & J. J. Palvimo: The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J Biol Chem, 277, 30283-8 (2002)
103. Sharma, M., X. Li, Y. Wang, M. Zarnegar, C. Y. Huang, J. J. Palvimo, B. Lim & Z. Sun: hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci. Embo J, 22, 6101-14 (2003)
104. Cheng, J., D. Wang, Z. Wang & E. T. Yeh: SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol, 24, 6021-8 (2004)
105. Bies, J., J. Markus & L. Wolff: Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J Biol Chem, 277, 8999-9009 (2002)
106. Shang, Y., X. Hu, J. DiRenzo, M. A. Lazar & M. Brown: Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell, 103, 843-52 (2000)
107. Gross, M., B. Liu, J. Tan, F. S. French, M. Carey & K. Shuai: Distinct effects of PIAS proteins on androgenmediated gene activation in prostate cancer cells. Oncogene, 20, 3880-7 (2001)
108. Gross, M., R. Yang, I. Top, C. Gasper & K. Shuai: PIASy-mediated repression of the androgen receptor is independent of sumoylation. Oncogene, 23, 3059-66 (2004)
109. Culig, Z., H. Klocker, G. Bartsch, H. Steiner & A. Hobisch: Androgen receptors in prostate cancer. J Urol, 170, 1363-9 (2003)
110. Grossmann, M. E., H. Huang & D. J. Tindall: Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst, 93, 1687-97 (2001)
111. Li, P., X. Yu, K. Ge, J. Melamed, R. G. Roeder & Z. Wang: Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am J Pathol, 161, 1467-74 (2002)
112. Junicho, A., T. Matsuda, T. Yamamoto, H. Kishi, K. Korkmaz, F. Saatcioglu, H. Fuse & A. Muraguchi: Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells. Biochem Biophys Res Commun, 278, 9-13 (2000)
113. Callewaert, L., V. Christiaens, A. Haelens, G. Verrijdt, G. Verhoeven & F. Claessens: Implications of a polyglutamine tract in the function of the human androgen receptor. Biochem Biophys Res Commun, 306, 46-52 (2003)
114. Sentis, S., M. Le Romancer, C. Bianchin, M. C. Rostan & L. Corbo: SUMOylation of the Estrogen receptor {alpha} hinge region by SUMO-E3 ligases PIAS1 and PIAS3 regulates ER {alpha} transcriptional activity. Mol Endocrinol (2005)
115. Leo, C. & J. D. Chen: The SRC family of nuclear receptor coactivators. Gene, 245, 1-11 (2000)
116. Krogan, N. J., J. Dover, A. Wood, J. Schneider, J. Heidt, M. A. Boateng, K. Dean, O. W. Ryan, A. Golshani, M. Johnston, J. F. Greenblatt & A. Shilatifard: The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation. Mol Cell, 11, 721-9 (2003)
117. Xiao, B., J. R. Wilson & S. J. Gamblin: SET domains and histone methylation. Curr Opin Struct Biol, 13, 699-705 (2003)
118. Tremblay, A., G. B. Tremblay, F. Labrie & V. Giguere: Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol Cell, 3, 513-9 (1999)
119. Kobayashi, S., H. Shibata, K. Yokota, N. Suda, A. Murai, I. Kurihara, I. Saito & T. Saruta: FHL2, UBC9, and PIAS1 are novel estrogen receptor alpha-interacting proteins. Endocr Res, 30, 617-21 (2004)